| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a05de5345a1d16e34603ae07b8e52a9a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0393
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2207-05 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0008 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027 |
| filingDate |
2020-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd4ba4f0a0bedbf9a00e60907927a27b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ddfc4878855d108a2b89cd3636f28fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1eca1c6d264b8e73e66281e2e66deae7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a92c1f26f3c3216c53b9ad5ab7dab07 |
| publicationDate |
2020-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-111387143-A |
| titleOfInvention |
Application of miRNA-203a-3p in the development of anti-pancreatic cancer drugs |
| abstract |
The present invention provides the application of miRNA-203a-3p in the development of drugs for inhibiting pancreatic cancer, 1) preparing a model for screening drugs for inhibiting pancreatic cancer metastasis; 2) preparing a model for inhibiting pancreatic cancer metastasis; the core of miRNA-203a-3p The nucleotide sequence is shown in SEQ ID NO:1. The present invention finds that miR-203a-3p cannot inhibit the proliferation and tumor formation of pancreatic cancer cells. However, it can induce the negatively correlated expression of the metastasis-related gene CERKL in pancreatic cancer cells, and can be used to prepare a mouse model for inhibiting pancreatic cancer metastasis. ) as a tool to develop mechanisms for metastatic tumors (pancreatic cancer). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112106729-A |
| priorityDate |
2020-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |